Related Experiment Video
Updated: Oct 27, 2025
Zebrafish Model of Neuroblastoma Metastasis
Published on: March 14, 2021
Loss of smarcad1a accelerates tumorigenesis of malignant peripheral nerve sheath tumors in zebrafish
Han Han1, Guangzhen Jiang1, Rashmi Kumari1
1Department of Comparative Pathobiology, Purdue University, West Lafayette, Indiana, USA.
Abstract:
Malignant peripheral nerve sheath tumors (MPNSTs) are a type of sarcoma that generally originates from Schwann cells. The prognosis for this type of malignancy is relatively poor due to complicated genetic alterations and the lack of specific targeted therapy. Chromosome fragment 4q22-23 is frequently deleted in MPNSTs and other human tumors, suggesting tumor suppressor genes may reside in this region. Here, we provide evidence that SMARCAD1, a known chromatin remodeler, is a novel tumor suppressor gene located in 4q22-23. We identified two human homologous smarcad1 genes (smarcad1a and smarcad1b) in zebrafish, and both genes share overlapping expression patterns during embryonic development. We demonstrated that two smarcad1a loss-of-function mutants, sa1299 and p403, can accelerate MPNST tumorigenesis in the tp53 mutant background, suggesting smarcad1a is a bona fide tumor suppressor gene for MPNSTs. Moreover, we found that DNA double-strand break (DSB) repair might be compromised in both mutants compared to wildtype zebrafish, as indicated by pH2AX, a DNA DSB marker. In addition, both SMARCAD1 gene knockdown and overexpression in human cells were able to inhibit tumor growth and displayed similar DSB repair responses, suggesting proper SMARCAD1 gene expression level or gene dosage is critical for cell growth. Given that mutations of SMARCAD1 sensitize cells to poly ADP ribose polymerase inhibitors in yeast and the human U2OS osteosarcoma cell line, the identification of SMARCAD1 as a novel tumor suppressor gene might contribute to the development of new cancer therapies for MPNSTs.
Insights
SMARCAD1 is identified as a novel tumor suppressor gene in malignant peripheral nerve sheath tumors (MPNSTs). Its loss-of-function accelerates MPNSTs and impairs DNA double-strand break repair, suggesting therapeutic potential.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Malignant peripheral nerve sheath tumors (MPNSTs) have a poor prognosis due to complex genetic changes and lack of targeted therapies.
- Chromosome region 4q22-23 deletions in MPNSTs suggest the presence of tumor suppressor genes.
- SMARCAD1 is a known chromatin remodeler with potential tumor suppressor functions.
Purpose of the Study:
- To investigate SMARCAD1 as a novel tumor suppressor gene in MPNSTs.
- To explore the role of SMARCAD1 in DNA double-strand break (DSB) repair.
- To assess the therapeutic potential of targeting SMARCAD1 in MPNSTs.
Main Methods:
- Identification and characterization of zebrafish smarcad1 homologs (smarcad1a and smarcad1b).
- Analysis of smarcad1a loss-of-function mutants in zebrafish MPNST models.
- Assessment of DNA DSB repair markers (pH2AX) in zebrafish and human cell lines.
- SMARCAD1 gene knockdown and overexpression studies in human cells.
- Evaluation of SMARCAD1 mutation sensitivity to poly ADP ribose polymerase (PARP) inhibitors.
Main Results:
- Two zebrafish smarcad1 genes, smarcad1a and smarcad1b, were identified with overlapping embryonic expression.
- smarcad1a loss-of-function mutants accelerated MPNST tumorigenesis in a tp53 mutant background.
- DNA DSB repair appeared compromised in smarcad1a mutants, indicated by pH2AX.
- SMARCAD1 modulation in human cells affected tumor growth and DSB repair responses.
- SMARCAD1 mutations sensitized cells to PARP inhibitors.
Conclusions:
- SMARCAD1 functions as a novel tumor suppressor gene in MPNSTs.
- Proper SMARCAD1 gene dosage is critical for cell growth and DNA DSB repair.
- SMARCAD1 represents a potential therapeutic target for MPNSTs, possibly in combination with PARP inhibitors.
